Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML

Clinical trial NCT02255162 · TERMINATED

Trial details

NCT number: NCT02255162
Sponsor: Massachusetts General Hospital
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Acute Myelocytic Leukemia Acute Myelogenous Leukemia Acute Granulocytic Leukemia Acute Non-Lymphocytic Leukemia

Start date: 2015-01-01
Primary completion: 2016-12-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.